Acute Mental Fatigue and Muscle Strength
Influence of Acute Mental Fatigue on Muscle Strength and Limb Symmetry in Healthy Adults
1 other identifier
interventional
50
1 country
1
Brief Summary
This study will investigate the acute effects of mental fatigue on lower-extremity muscle strength and limb symmetry in healthy young adults. Participants will complete lower-extremity strength testing before and after a standardized computer-based mental fatigue protocol involving tasks of attention, reaction time, concentration, and working memory. Muscle strength and limb symmetry will be assessed using isokinetic dynamometry, with muscle activity measured using surface electromyography. Participants will also complete subjective measures of mental fatigue, sleepiness, mental effort, and perceived physical exertion. Heart rate will be monitored throughout the study, and brain activity may be assessed during cognitive tasks. The study will determine whether acute mental fatigue is associated with changes in muscle strength, limb symmetry, and neuromuscular performance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 23, 2026
CompletedStudy Start
First participant enrolled
September 23, 2026
CompletedFirst Posted
Study publicly available on registry
September 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
September 29, 2026
September 1, 2026
1.3 years
September 23, 2026
September 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Lower-Extremity Muscle Strength
Lower-extremity muscle strength will be assessed using a Biodex isokinetic dynamometer during bilateral knee extension and flexion at three different movement speeds. Peak torque will be recorded as the primary measure of muscle strength. Changes in peak torque from baseline to immediately following the computer-based mental fatigue intervention will be evaluated.
Baseline and immediately following the approximately 30-minute mental fatigue intervention, during a single study visit lasting up to 2 hours.
Lower-Extremity Limb Symmetry
Limb symmetry will be assessed using peak torque measurements obtained from both lower extremities during isokinetic knee extension and flexion testing. A Limb Symmetry Index (LSI) will be calculated to quantify the similarity in muscle strength between the two lower extremities. Changes in LSI from baseline to immediately following the computer-based mental fatigue intervention will be evaluated.
Baseline and immediately following the approximately 30-minute mental fatigue intervention, during a single study visit lasting up to 2 hours.
Study Arms (1)
Mental Fatigue Intervention
EXPERIMENTALParticipants will complete baseline lower-extremity muscle strength testing followed by approximately 30 minutes of standardized computer-based cognitive tasks designed to induce acute mental fatigue. Lower-extremity muscle strength testing will then be repeated immediately following the mental fatigue intervention.
Interventions
Participants will complete approximately 30 minutes of standardized computer-based cognitive tasks designed to induce acute mental fatigue. The tasks require sustained attention, concentration, reaction time, working memory, and mental effort and may include the Psychomotor Vigilance Task (PVT), incongruent Stroop task, and n-back task. Participants will complete the mental fatigue protocol after baseline strength testing and before the post-intervention strength assessment. Subjective mental fatigue and sleepiness will be assessed before and after the intervention, and perceived mental effort will be assessed following the intervention.
Eligibility Criteria
You may qualify if:
- Age 18-39 years
- Able to produce maximal force against Biodex protocol
- Able to perform required lower extremity movements through range of motion necessary for Biodex protocol
- No known cognitive impairment
- Sufficient musculoskeletal health to complete the tasks
You may not qualify if:
- History of a neurological disorder, disease, or cognitive impairment that may affect cognition, motor control, reaction time, or force production
- History of musculoskeletal injury affecting the lower extremities within the past 6 months
- History of lower extremity surgery affecting force production of the hip, knee, or ankle
- Color-vision impairment
- Significant visual or hearing impairment
- History of migraine headaches
- Current significant sleep disturbances or sleep deprivation
- Head injury that may affect cognitive function
- Medical condition affecting ability to produce maximal force safely
- Allergy to adhesive tape, parabens, or propylene glycol
- Scalp lacerations, open wounds, or sutures on the scalp
- Cranial surgery or skull defects
- History of unexplained dizziness or fainting in the past 6 months
- Individuals who are pregnant, prisoners, or not yet adults
- Inability to communicate with investigators
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Florida Institute for Human and Machine Cognition
Pensacola, Florida, 32502, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nicole K Rendos, PhD
Florida Institute for Human and Machine Cognition
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Scientist
Study Record Dates
First Submitted
September 23, 2026
First Posted
September 29, 2026
Study Start
September 23, 2026
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
September 29, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will be available beginning 12 months and ending 36 months following publication of the primary findings from this study.
- Access Criteria
- De-identified data may be shared with scientific and clinical researchers for research purposes, including individual participant data meta-analyses. Requests for data should be directed to Dr. Nicole Rendos at nrendos@ihmc.org and may be submitted up to 36 months following publication of the primary findings from this study. Researchers requesting access will be required to provide an appropriate scientific rationale for the request and sign a data access agreement before receiving the data.
De-identified individual participant data that underlie the results reported in publications from this study may be made available to other researchers for scientific research purposes. Data will be shared without information that directly identifies participants.